Senior Director, Clinical Research - Neurodegeneration at Alnylampharmaceuticals | JobGan

Senior Director, Clinical Research - Neurodegeneration

Alnylampharmaceuticals
Full time Senior
📡 Maidenhead, MA 🏙 Maidenhead, England 📅 Dec 31, 1969 ⏳ Closes Dec 20, 2026
💰 $180,000 – $207,000 CAD/yr
📋 Job Description

The Senior Director, Clinical Research at Alnylam Pharmaceuticals will lead the clinical development of innovative RNAi therapeutics, primarily focusing on Huntington's program while supporting various therapeutic areas. This role involves strategic leadership in clinical programs, overseeing trial conduct, and ensuring regulatory compliance. Ideal candidates will possess an MD or MD PhD with extensive experience in clinical research and a strong background in drug development, particularly in n

🔓

Sign up free to read the full details

Create your free account in 10 seconds and instantly unlock the complete job listing.

⚙️Requirements 🕐 Schedule 🔧 Skills 🔗 Apply Link

No spam · Free forever · Unsubscribe any time

Free Professional Certification & Career Pathway
Professional Employment Recommendation Certificate [Free]

Getting certified and Getting hired.



Access free courses, free exams, and verified certificates designed to build real, job-ready skills. Join a growing hiring network that connects learning directly to opportunities. This is not just training—it’s a pathway to getting certified and getting hired.

Click and Go to Course Library

HIRING COMPANY:
Alnylampharmaceuticals
📡 Maidenhead
Alnylam Pharmaceuticals, a leader in the biotechnology industry, focuses on pioneering RNA interference (RNAi) as a transformative approach to medicine. The company is committed to developing innovative therapies for rare and prevalent diseases, aiming to change lives through groundbreaking research. Alnylam fosters a …

Ready to Apply?

Submit your application directly to Alnylampharmaceuticals.

Free sign-up unlocks the full listing + apply link
⏳ Closes Dec 20, 2026
Senior Director, Clinical Research - Neurodegeneration
Alnylampharmaceuticals · $180,000 – $207,000 CAD/yr